• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation.

作者信息

Kim Eileen, Walker Amanda, Bhate Chinmoy, Chang Victor T

机构信息

Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

出版信息

Dermatol Ther. 2022 Oct;35(10):e15751. doi: 10.1111/dth.15751. Epub 2022 Aug 14.

DOI:10.1111/dth.15751
PMID:35912707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9786349/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/9786349/dd24f087353f/DTH-35-e15751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/9786349/dd24f087353f/DTH-35-e15751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ee/9786349/dd24f087353f/DTH-35-e15751-g001.jpg

相似文献

1
Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation.蕈样肉芽肿伴大细胞转化患者的 Brentuximab 外渗损伤
Dermatol Ther. 2022 Oct;35(10):e15751. doi: 10.1111/dth.15751. Epub 2022 Aug 14.
2
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association.在用维布妥昔单抗治疗蕈样肉芽肿患者时出现点滴状银屑病：一种未报道的关联。
Dermatol Ther. 2022 Apr;35(4):e15309. doi: 10.1111/dth.15309. Epub 2022 Jan 12.
3
Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin.蕈样肉芽肿病伴 CD30 阳性大细胞转化经 Brentuximab vedotin 治疗后成功缓解。
Dermatol Ther. 2020 Jan;33(1):e13152. doi: 10.1111/dth.13152. Epub 2019 Nov 19.
4
Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin.用维布妥昔单抗治疗CD30阴性难治性蕈样肉芽肿
JAMA Dermatol. 2018 Jan 1;154(1):109-110. doi: 10.1001/jamadermatol.2017.3961.
5
Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.CD30 阴性、治疗抵抗的蕈样肉芽肿对 Brentuximab vedotin 治疗的显著反应。
Dermatol Ther. 2019 Mar;32(2):e12835. doi: 10.1111/dth.12835. Epub 2019 Feb 17.
6
Treatment of mycosis fungoides with brentuximab vedotin: Assessing CD30 expression by immunohistochemistry and quantitative real-time polymerase chain reaction.用维布妥昔单抗治疗蕈样肉芽肿：通过免疫组织化学和定量实时聚合酶链反应评估CD30表达
J Cutan Pathol. 2022 Mar;49(3):314-317. doi: 10.1111/cup.14178. Epub 2021 Dec 22.
7
Evaluation of new tumors in the setting of stage I/IIA mycosis fungoides.I/IIA期蕈样肉芽肿患者新肿瘤的评估
Clin Lymphoma Myeloma. 2007 Jul;7(7):480-5. doi: 10.3816/clm.2007.n.032.
8
Advanced-Stage CD30 Mycosis Fungoides Treated With Brentuximab.用本妥昔单抗治疗的晚期CD30蕈样肉芽肿
Actas Dermosifiliogr. 2022 May;113(5):529-531. doi: 10.1016/j.ad.2020.05.021. Epub 2021 Nov 10.
9
Alitretinoin treatment in mycosis fungoides with CD30-positive large cell transformation.阿利维A酸治疗蕈样肉芽肿伴CD30阳性大细胞转化
Clin Exp Dermatol. 2017 Apr;42(3):341-342. doi: 10.1111/ced.13046. Epub 2017 Feb 16.
10
RF - Brentuximab as Treatment for CD30 Primary Cutaneous Lymphoma.利妥昔单抗 - 本妥昔单抗治疗CD30原发性皮肤淋巴瘤
Actas Dermosifiliogr (Engl Ed). 2019 Nov;110(9):769-770. doi: 10.1016/j.ad.2018.03.025. Epub 2019 May 28.

本文引用的文献

1
Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.皮肤 T 细胞淋巴瘤：2021 年诊断、风险分层和治疗更新。
Am J Hematol. 2021 Oct 1;96(10):1313-1328. doi: 10.1002/ajh.26299. Epub 2021 Aug 2.
2
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE).单甲基澳瑞他汀E（MMAE）的全身药代动力学及基于生理学的药代动力学模型
J Clin Med. 2021 Mar 23;10(6):1332. doi: 10.3390/jcm10061332.
3
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models.
具有高旁观者和细胞毒性活性的新型 Auristatins 用于药物外排阳性肿瘤模型。
Mol Cancer Ther. 2021 Feb;20(2):320-328. doi: 10.1158/1535-7163.MCT-20-0618. Epub 2020 Dec 7.
4
Demyelinating neuropathy and local toxicity caused by extravasated Brentuximab vedotin.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e626-e628. doi: 10.1111/jdv.16502. Epub 2020 May 27.
5
Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.皮肤 T 细胞淋巴瘤：揭开诊断之谜。
Dermatol Clin. 2019 Oct;37(4):455-469. doi: 10.1016/j.det.2019.05.007.
6
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.2018 年版 WHO-EORTC 原发性皮肤淋巴瘤分类。
Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11.
7
Cytotoxic extravasation: an issue disappearing or a problem without solution?
Tumori. 2016 Jun 2;2016(3):290-3. doi: 10.5301/tj.5000486. Epub 2016 Mar 22.
8
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.采用标准化管理方案的大量患者化疗外渗的结局
Support Care Cancer. 2015 Jun;23(6):1741-8. doi: 10.1007/s00520-014-2535-2. Epub 2014 Nov 30.